ARE WE GETTING ANY CLOSER?

Serial Number 85195513
606

Registration Progress

Application Filed
Dec 10, 2010
Under Examination
Jun 21, 2011
Approved for Publication
Apr 6, 2011
Published for Opposition
Apr 26, 2011
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: ARE WE GETTING ANY CLOSER?
Previous Owner: AGENUS INC.
Classes: 005

Trademark Image

ARE WE GETTING ANY CLOSER?

Basic Information

Serial Number
85195513
Filing Date
December 10, 2010
Published for Opposition
April 26, 2011
Abandonment Date
January 23, 2012
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 23, 2012
Classes
005

Rights Holder

AGENUS INC.

03
Address
3 Forbes Road
Lexington, MA 02421

Ownership History

Antigenics Inc.

Original Applicant
03
Lexington, MA

AGENUS INC.

New Owner Before Publication #1
03
Lexington, MA

AGENUS INC.

Owner at Publication
03
Lexington, MA

Legal Representation

Attorney
Christina M. Licursi

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

11 events
Date Code Type Description Documents
Jan 23, 2012 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Jan 23, 2012 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jun 21, 2011 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 26, 2011 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 6, 2011 NPUB O NOTICE OF PUBLICATION Loading...
Mar 18, 2011 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 14, 2011 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 16, 2011 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Feb 16, 2011 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Feb 7, 2011 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Dec 15, 2010 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical and biopharmaceutical agents, namely, vaccines and immunotherapeutics, for the prevention and treatment of human diseases in the fields of autoimmunity, oncology, and infectious diseases
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005